Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian C. Tripp is active.

Publication


Featured researches published by Brian C. Tripp.


Journal of Biomolecular Screening | 2006

Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds.

Rema Iyer; Albert A. Barrese; Shilpa Parakh; Christian N. Parker; Brian C. Tripp

Human carbonic anhydrase II (CA II), a zinc metalloenzyme, was screened against 960 structurally diverse, biologically active small molecules. The assay monitored CA II esterase activity against the substrate 4-nitrophenyl acetate in a format allowing high-throughput screening. The assay proved to be robust and reproducible with a hit rate of ∼2%. Potential hits were further characterized by determining their IC50 and Kd values and tested for nonspecific, promiscuous inhibition. Three known sulfonamide CA inhibitors were identified: acetazolamide, methazolamide, and celecoxib. Other hits were also found, including diuretics and antibiotics not previously identified as CA inhibitors, for example, furosemide and halazone. These results confirm that many sulfonamide drugs have CA inhibitory properties but also that not all sulfonamides are CA inhibitors. Thus many, but not all, sulfonamide drugs appear to interact with CA II and may target other CA isozymes. The screen also yielded several novel classes of nonsulfonamide inhibitors, including merbromin, thioxolone, and tannic acid. Although these compounds may function by some nonspecific mechanism (merbromin and tannic acid), at least 1 (thioxolone) appears to represent a genuine CA inhibitor. Thus, this study yielded a number of potentially new classes of CA inhibitors and preliminary experiments to characterize their mechanism of action.


Biochemistry | 2008

Inhibition of Carbonic Anhydrase II by Thioxolone: A Mechanistic and Structural Study.

Albert A. Barrese; Caroli Genis; S. Zoë Fisher; Jared N. Orwenyo; Mudalige Thilak Kumara; Subodh K. Dutta; Eric Phillips; James J. Kiddle; Chingkuang Tu; David N. Silverman; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Robert McKenna; Brian C. Tripp

This paper examines the functional mechanism of thioxolone, a compound recently identified as a weak inhibitor of human carbonic anhydrase II by Iyer et al. (2006) J. Biomol. Screening 11, 782-791 . Thioxolone lacks sulfonamide, sulfamate, or hydroxamate functional groups that are typically found in therapeutic carbonic anhydrase (CA) inhibitors, such as acetazolamide. Analytical chemistry and biochemical methods were used to investigate the fate of thioxolone upon binding to CA II, including Michaelis-Menten kinetics of 4-nitrophenyl acetate esterase cleavage, liquid chromatography-mass spectrometry (LC-MS), oxygen-18 isotope exchange studies, and X-ray crystallography. Thioxolone is proposed to be a prodrug inhibitor that is cleaved via a CA II zinc-hydroxide mechanism known to catalyze the hydrolysis of esters. When thioxolone binds in the active site of CA II, it is cleaved and forms 4-mercaptobenzene-1,3-diol via the intermediate S-(2,4-thiophenyl)hydrogen thiocarbonate. The esterase cleavage product binds to the zinc active site via the thiol group and is therefore the active CA inhibitor, while the intermediate is located at the rim of the active-site cavity. The time-dependence of this inhibition reaction was investigated in detail. Because this type of prodrug inhibitor mechanism depends on cleavage of ester bonds, this class of inhibitors may have advantages over sulfonamides in determining isozyme specificity. A preliminary structure-activity relationship study with a series of structural analogues of thioxolone yielded similar estimates of inhibition constants for most compounds, although two compounds with bromine groups at the C1 carbon of thioxolone were not inhibitory, suggesting a possible steric effect.


Journal of Physical Chemistry B | 2008

Determination of the Line Tension of Giant Vesicles from Pore-Closing Dynamics

Narayanan Srividya; Subra Muralidharan; Wilson Okumu; Brian C. Tripp

Giant vesicles generated from synthetic and natural lipids such as phosphatidylcholines are useful models for understanding mechanical properties of cell membranes. Line tension is the one-dimensional force enabling the closing of transient pores on cell membranes. Transient pores were repeatedly and reproducibly formed on the membrane edge of giant vesicles generated from synthetic and natural phosphatidylcholines employing a nitrogen-pumped coumarin dye laser (440 nm). Line tension was determined at room temperature from closing of these pores that occurred over several seconds when the radius of the vesicle could be considered to be constant. The value of line tension depends on the nature of the lipid for single lipid systems, which, at room temperature, yielded a vesicle bilayer region in the gel, fluid, or mixed gel and fluid phases. The line tension for vesicles generated from phosphatidylcholines with saturated acyl chains of lengths of 12-18 carbon atoms ranges from 1 to 12 pN, exhibiting an increase with chain length. Vesicles generated from the natural Egg-PC, which is a mixture of lipids, are devoid of phase transition and exhibited the largest value of line tension (32 pN). This value is much larger than that estimated from the line tensions of vesicles obtained from lipids with homologous acyl chains. This study, to our knowledge, is the first to employ laser ablation to generate transient pores and determine line tension from the rate of pore closure and demonstrate a relationship between line tension and acyl chain length.


Journal of Biomolecular Screening | 2007

High-Throughput Screening for Antimicrobial Compounds Using a 96-Well Format Bacterial Motility Absorbance Assay

Venkata R.R. Malapaka; Albert A. Barrese; Brian C. Tripp

There is a pressing need to develop new antimicrobial drugs because of the increasing resistance of pathogenic bacteria to existing antibiotics. The preliminary development and validation of a novel methodology for the high-throughput screening of antimicrobial compounds and inhibitors of bacterial motility is described. This method uses a bacterial motility swarming agar assay, combined with the use of offset inoculation of the wells in a standard, clear, 96-well plate, to enable rapid screening of compounds for potential antibiotic and antimotility properties with a standard absorbance microplate reader. Thus, the methodology should be compatible with 96-well laboratory automation technology used in drug discovery and chemical biology studies. To validate the screening method, the Genesis Plus structurally diverse library of 960 biologically active compounds was screened against a motile strain of the gram-negative bacterial pathogen Salmonella typhimurium. The average Z′ value for the positive and negative motility controls on all 12 compound plates was 0.67 ± 0.14, and the signal-to-baseline ratio calculated from the positive and negative controls was 5.9 ± 1.1. A collection of 70 compounds with well-known antimicrobial properties was successfully identified using this assay. (Journal of Biomolecular Screening 2007:849-854)


Journal of Biological Chemistry | 2001

Carbonic Anhydrase: New Insights for an Ancient Enzyme

Brian C. Tripp; Kerry S. Smith; James G. Ferry


Journal of Biological Chemistry | 2004

A Role for Iron in an Ancient Carbonic Anhydrase

Brian C. Tripp; Caleb B. Bell; Francisco Cruz; Carsten Krebs; James G. Ferry


Chemistry of Materials | 2007

Self-assembly of metal nanoparticles and nanotubes on bioengineered flagella scaffolds

Mudalige Thilak Kumara; Brian C. Tripp; Subra Muralidharan


Biochemistry | 2000

A Structure−Function Study of a Proton Transport Pathway in the γ-Class Carbonic Anhydrase from Methanosarcina thermophila†

Brian C. Tripp; James G. Ferry


Biochemistry | 2002

Chemical rescue of proton transfer in Catalysis by carbonic anhydrases in the β- and γ-class

Chingkuang Tu; Roger S. Rowlett; Brian C. Tripp; James G. Ferry; David N. Silverman


Nano Letters | 2006

Bioengineered flagella protein nanotubes with cysteine loops: self-assembly and manipulation in an optical trap.

Mudalige Thilak Kumara; Narayanan Srividya; Subra Muralidharan; Brian C. Tripp

Collaboration


Dive into the Brian C. Tripp's collaboration.

Top Co-Authors

Avatar

James G. Ferry

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Subra Muralidharan

Western Michigan University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Albert A. Barrese

Western Michigan University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carsten Krebs

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francisco Cruz

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Narayanan Srividya

Western Michigan University

View shared research outputs
Researchain Logo
Decentralizing Knowledge